45th Annual Report – 2010-11
 
The Annual Report is a chronicle of various initiatives and multi-dimensional activities of the various OPPI Special Committees during the year 2010-11.

OPPI Code of Pharmaceutical Marketing Practices - 2010

This code sets out standards for the ethical promotion of pharmaceutical products to healthcare professionals to ensure that companies’ interactions with healthcare professionals are appropriate and perceived as such.

India emerging - Pharma's evolving business models
(OPPI & E&Y Report)

India emerging: Pharma's evolving business models is the third part in a series of reports by the OPPI and Ernst & Young that focuses on India as a pharmaceutical destination.

Transforming Life Sciences Logistics in India
(OPPI & DHL report)

"Transforming Life Sciences Logistics in India" invites the attention of business leaders (both life sciences and logistics professionals), relevant government authorities, infrastructure developers, private logistics players, and anyone else keen to understand how India can achieve a world-class life sciences (LS) logistics setup.

The Evolution of Sales Models in the Indian Pharma Industry
(OPPI & IMS Report)

The ever changing face of the Indian pharma industry and its ability to adapt innovatively has reinforced the fact that adaptation is the only way to survive. With every passing decade, a new commercial challenge has emerged; which in-turn has provided the industry with an opportunity to ride the waves to reach newer heights.

Lean implementation - Indian pharmaceutical industry
(OPPI & PwC Report)

Over the last decade many Pharma organizations across India have started adopting various excellence initiatives. These initiatives are supposed to aid organizations in creating value and & help face the challenging business needs. This survey was designed to check the status of current lean implementation in pharma companies.

 

Achieving Growth with Responsibility
(OPPI & NMIMS Report)

This study has used the latest CSR paradigm in its discussion and analysis and addresses the CSR related challenges of the pharmaceutical companies through a combination of academic perspectives, as well as practitioners’ insights.

Successful Partnerships
(OPPI and E & Y Report)

The report gives an insight on working with Indian pharmaceutical service providers to the leadership of global pharmaceutical companies and service providers in India on what it takes to create successful and enduring partnerships.

Corporate Social Responsibility Update - 2010
Caring for Society

The report showcases the CSR initiatives of OPPI Member Companies in areas like Access, Patient Awareness, Medical Education, Capacity Building and Collaboration with Government, Public, NGOs and others.

OPPI & Ernst & Young Report 2009 - Taking Wings

The report characterizes the Indian outsourcing landscape, its capabilities, challenges and opportunities, all of which could make India a preferred destination for partnering, especially when outsourcing decisions are increasingly becoming strategic in nature.

OPPI Guidelines on Cold Chain Pharmaceutical Products

The guidelines capture the expectations from each stakeholder on Cold Chain management systems to ensure that the patient gets the same high quality medicines medicinal products which are manufactured under strict quality control system in GMP compliant facilities.

OPPI Code on Conduct of Clinical Trials

This code covers Pharmaceutical Industry, including biotech industry sponsored interventional Phase 1 to 4 trials involving human subjects, and applicable for post marketing drug / non drug interventional or observational studies as well.

OPPI - YES Bank Report, "Pharmaceutical Industry: Vision 2015"

This report examines the way forward for the key constituents of the pharmaceutical sector, and contextualizes various structural changes in the domestic and Global Pharmaceutical Industry.